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LETTER TO THE EDITOR 
HTL V -I and CTCL: The Link is Missing 
To the Editor: 
We read with great interest the paper of Khan et al (1996) 
describing the localization of human T-cell Iymphotropic virus 
type-I (HTL V -I) tax proviral sequ ences in skin biopsies of mycosis 
fungoides utilizing ill silll polymerase chain reaction (PCR) . In their 
stud y, 11 of 12 skin biopsies from patients with mycosis fungoides 
demonstrated positi ve tax signal localized over dermal and epider-
mal infiltrating lymphocytes. T hey sta te " demonstration that the 
lymphocytes in the skin bi opsies of these patients harbor H TL V-I 
proviral sequences seems beyond cavil. " Yet, they fail to dem on-
strate rhe specificity of the tax signal through the use of appropriate 
negative controls (a reaction without Taq polymerase or with an 
irrelevant primer pair or with a nonspeci.fi c probe). In som e cases, 
tax signal was detected over keratinocytes ill les ional skin; how-
ever, a comparison with negative controls (normal o r unin volved 
skin) a nd positi ve controls (skin fi·om a seropositive HTLV-I-
infected patient) is not provided . T he authors conclude that ill Silll 
PCR studies of HTLV-l tax proviral sequences can help establish 
the diagnosis of mycosis fungoides. We take exception to their 
conclusion because a critical evaluation of the published reports in 
the world's literature will support the conclusion that H TLV-I docs 
not playa role in the pathogenesis of cutaneous T -cell lymphom a 
(mycoses fun goides/Sezary syndrome)(CTCL). 
In six series (Capesius et ai , 199 1; Lisby et ai, 1992; Bazarbachi ct 
ai, 1993; Boni CI ai , 1996; Li Cl ai, 1996; Wood ci ai, 1996) PCR 
amplification was utilized to detect HTL V -I proviral sequences in a 
total of 205 patients fi·om Euro pe and the United States. No 
I evidence of HTLV-I proviral DNA was detected in any of the 
patient s screened (01205). In ano ther fo ur reports (D'lnc:ln et ai, 
I 1992; Srivastava et al. 1992; C han el ai, 1993; Whittaker and 
Luzzatto, 1993), a total of176 patients from Europe and the United 
States were screened. I-ITLV-I proviral sequences were detect in 18 
patients (10%). Two studies (Ghosh et ai, 1994; Pancake el ai, 1995) 
have screened a total of 75 patients from the United States and 
detected I-ITLV-I proviral DNA in 64 patients (85'X) . Overall , the 
detection rate is 18% (84/456). 
To date, no definitiv e model of HTL V -I infection in CTCL has 
been a d vanced or confirmed . T runcated proviruses and low copy 
number (Hail et ai, 1991 ; Z ucker-Franklin el aI, 1991) have been 
advan ced as factors influencing detection rates of HTLV -I and the 
lack of antibody response seen in CTCL (Srivastava et al. 1992). If 
such mechanisms are associated with HTL V -I in fection in CTCL, 
then an entirely new and yet to be confirmed I-ITLV-I virology 
mus t b e operative in CTCL, because it is neither endemic for areas 
ofHTL V -I infection (Weinstock and Homl, 1988) nor does CTCL 
have the clinicopathologic features of endemic I-ITL V -I-associated 
adult T - cell leukemia/ lymphom a in the majo ri ty of cases (DiCaudo 
et ai, 1996). 
The occasional detection of H TLV-I proviral DNA in CTCL 
patients m ost likely is a result of one or more facto rs: (i) inaccurate 
diagnosis of CTCL in some patients (i.e. , inclusion of one 0 1· more 
patients likely to have adult T -cell leukemia/ lympho ma based on 
their classic HTLV-I seropositi vity [e.g., Pancake 1ft ai, 1995)]; (ii) 
second ary infection related to CTCL immun osuppression (Heald c/ 
ai, 1994); (iii) ampl.ifica tion of endogeno us retrovirus-like genes 
(Mager and Freeman, 1987); (iv) trace con tamination of samples 
(Wood el ai, 1996). T he high detection rates reported in on ly two 
studies requires careful interpretation (Ghosh e/ ai, 1994; Pancake et 
ai, 1995). Fint, none of these studies demonstrated genomic 
integration of I-ITLV -I. precluding any definitive conclusions re-
garding a potential mechanism or site of HTLV -I infection in 
CTCL. O ne of these groups (Ghosh e/ ai, 1994) has previously 
published similar PCR detection of HTLV-I DNA in multiple 
sclerosis (Reddy et aI, 1989), which subsequent studies have failed 
to confirm (Winkelman, 1993). The laboratOl), of Kllan et ai, 
although publishing PCR detection rates of 92% in tlIe peripheral 
blood (Pancake et ai, 1995), has never correlated or tested their 
PCR methods in skin. Instead, they introduce the use of i ll sitll PCR 
to detect I-ITL V -I DNA in CTCL without appropriate controls and 
without addressing their detection rate of whole-tissue PCR am-
plification in their skin biopsies. 
Based on the currently available m olecular and epidemiologic 
data, .it is clear that H TL V -I is nOt a primary etiologic agent in the 
pathogenesis of CTCL. We therefore feel that tile use of ill 'sit ll 
PC R detection of HTL V -T tax proviral seq uences as a diagnostic 
tool in CTCL is not va lid . 
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Reply: 
Medical science does not advance by turning the clock backward. 
N ew methods, more sensitive methods, or, as in this case, a change 
in methods has yielded results which have been sought by a large 
number of investigators, many of whom have been cited in the 
letter submitted by Drs. Lessin, Rook, Li, and Wood. Negative 
results can, of course, not prove anything. In addition, nobody 
would claim, at the present time, that HTLV -I tax is causally 
related to mycosis fungoides. However, that such proviral se-
quences are harbored in the lymphocytes of most of these patients 
(whether in th eir blood lymphocytes or those infiltrating the skin) 
is beyol/d ca lli/ . 
Tt is more constructive to learn why so many in vestigators have 
failed to detect these sequences and why so few patients with bona 
fide CTCL have antibodies to the structural proteins of the virus. 
We have meticulously carried out such an analysis on 10 
specimens comparing our methods with those used by others, 
including those used in the papers cited by Drs . Lessin el al (Pancake 
and Zucker-Franklin, in press). The major differences are as 
follows: (i) the state and condition of the cells used , i. e ., freshly 
isolated lIerSIIS cultured or cells fixed in various ways. The la tter 
applies particul arly to skin biopsies that are almost always negative 
unless the specimens are fresh ly obtained or frozen; (ii) preparation 
of specim ens for PCR, i.e ., whole celllysates verslls DNA extracts; 
(iii) the HTLV sequen ce targeted, i.e., tax lIerSIIS other regions of 
the HTLV-proviral genome; (iv) whether or not Southern hybl;d-
ization is used in combination with PCR. The use of DNA extracts 
rather than whole-cell Iysates may be the most important short-
coming in the m ethods used by less successfill authors. A paper 
detailing these various methods is in press (Pancake and Zucker-
Franklin, in press). 
THE J OURNAL OF INVESTIGATIVE DERMATOLOGY 
Since the vast majority of patients with CTCL have HTLV-I 
proviral sequences in their pel-ipheral blood lymphocytes (Pancake 
et nl, 1995), it should not be surprising to find these also in 
lymphocytes infiltrating the skin. We have, of course, done 
PCR/Southern ana lyses on skin biopsies (e.g. , Zucker-Franklin el 
aI, 1994), but this exercise did not identify the specific cells, 
harboring the viI·al sequences, which was done in the paper ullder 
discussion. 
The concern over the finding of BTL V-I tax sequences in the 
lymphocytes of patients with m ycosis fungoides may be alleviated 
by our observation that all patients who have demonstrable tax 
sequences also have tax mRNA (Pancake el aI, 1995) and the 
majority have antibodies to tax without having antibodies to the 
structural proteins of the virus (Pancake el nl, 1996; Pancake el nl, in 
press). 
Indeed , it is unfortunate that the correspondents raise questions 
that have long been settled by others. For instance, they question 
whether we are detecting endogenous retroviral sequences when it 
is generally recognized that tax, the putative HTL V -transforming 
sequence, does not share homology with any human DNA se-
quences. They also question whether the diagnosis of CTCL was 
accurate when the dermatology department at N ew York Univer-
sity is one of the largest referral centers for this disease in the 
country . (By now we have studied upward of 150 mycosis fun-
goides patients -mostly Caucasian Americans who are positive for 
HTLV-I tax sequences). Mycosis fungoides does not seem to be an 
endemic disease, but the same pathogen , HTLV-I, has been shown 
to be associated with diseases as divergent as ATL and TSP/HAM. 
Let us now move forward! 
Dorothea Zucker-Franklin 
Department of Medicine 
New York University School of Medicine 
New York, N ew York 
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